glp-1 agonist alzheimer's Antidiabetic Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Disease Frontiers | GLP-1R as a

Lactobacillus plantarum TWK10 improves muscle mass and functional performance in frail older adults: a randomized, double-blind clinical trial

Traditionally, both single and combination FDA-approved drugs for obesity have shown moderate, but clinically-important, weight losses (mean weight loss of 3%9% greater than placebo at ~1 year of therapy) (4) (Figure 1)

Triple agonists usually cost more than proven dual agonists

doi: 10.1517/14656566.7.15.2095 143 PedrosaMRFrancoDRGieremekHWVidalCMBronzeriFde Cassia RochaAet al

MECHANISM OF ACTION GLP-1 analogs Glucagon-like peptide-1 (GLP-1) is a hormone secreted into the bloodstream by special cells in the intestine in response to food consumption

To the best of our knowledge, no clinical trials have or are currently investigating GLP1 receptor activation as a treatment of central stimulant use disorder in humans